Allikmets, L. X., Rjago, L. K. (1983). Uchastie raznich neyromediatornich system v mekhanismakh deystviya proizvodnich GAMK. [Participation of different neurotransmitter systems in mechanisms of action of GABA derivatives]. Summary of papers from the All-USSR Symposium “Pharmacology of derived gamma-aminobutyric acid. Tartu, 25-27 May 1983, p.7.
Avoli, M. (1996). GABA-mediated synchronous potentials and seizure generation. Epilepsia, 37, 1035–1042.
Basyan, A. S. (2001). Vzaimodeystvie mediatornikh i neuromodulatornikh system golovnogo mozga i ikh vozmozhnaya rol' v formirovanii psikhofisiologicheskikh i psikhopatologicheskikh sostoyaniy. [Interaction of brain mediatory and neuromodulator systems and their possible role in formation of psychophysiological and psychopathological states]. Zhurnal uspekhi fiziologicheskikh Nauk, 32, 3–22.
Bormann, J., Hamill, O. P., Sakmann, B. (1987). Mechanism of anion permeation through channels gated by glycine and gamma-aminobutyric acid in mouse cultures spinal neurones. Journal Physiology, 385, 243–286.
Brown, N., Kerby, J., Bonnert, T. P., Whiting, P.J., Wafford, K.A. (2002). Pharmacological characterization of a novel cell expressing human alpha(4)beta(3)delta GABAA receptors. British Journal of Pharmacology, 136, 965–974.
Caraiscos, V. B., Elliott, E. M., You-Ten, K. E., Cheng, V. Y., Bellali, D., Newell, J. G. et al. , (2004). Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by a5 subunit-containing gamma-aminobutiric acid type A receptors. The Proceedings of the National Academy of Sciences of the USA, 101, 3662–3667.
Cheng, S. C., Brunner, E.A. (1985). Inducing anesthesia with a GABA analog, THIP. Anesthesiology, 63, 147–151.
Clemente, C.D. (1968). Forebrain mechanisms related to internal inhibition and sleep. Conditional Reflex, 3, 145–174.
Costa, E., Davis, J. M., Dong, E., Grayson, D. R., Guidotti, A., Tremolizzo, L., & Veldic, M. (2004). GABAergic cortical deficit dominates schizophrenia pathophysiology. Critical Review of Neurobiology, 16, 1–23.
Drew, C. A., Johnston, G. A., Weatherby, R.P. (1984). Bicucullineinsensitive GABA receptors: studies on the binding of (-)-baclofen to rat cerebellar membranes. Neuroscience Letters, 52, 317–321.
Eccles, J.C. (1964). The physiology of synapses. Berlin: Springer.
Eccles, J.C. (1969). The inhibitory pathways of the central nervous system. London: Liverpool University Press.
Eccles, J. C., McGreer, P. L. (1979). Ionotropic and metabotropic neurotransmission. Trends in Neuroscience, 2, 39–40.
Enomoto, T.F. & Ajmone-Marsan, C. (1959). Epileptic activation of single cortical neurons and their relationship with electroencephalographic discharges. Electroencephalography and Clinical Neurophysiology, 11, 199–218.
Farrant, M. (2001) Amino Acids: Inhibitory. In Webster, R.A. (Ed.), Neurotransmitters, Drugs and Brain Function. Hoboken, NJ: John Wiley & Sons. (pp. 225–250).
Faulhaber, J., Steiger, A., Lancel, M. (1997). The GABAA agonist THIP produces low wave sleep and reduces spindling activity in NREM sleep in humans. Psychopharmacology, 130, 285–291.
Hill, D. R., Bowery, N.G. (1981). 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA(B) sites in rat brain. Nature, 290 (5802), 149–152.
Huckle, R. (2004). Gabaxadol. Current Opinion in Investigational Drugs. 5, 766–773.
Johnston, G. A. R. (1996). GABAC receptors: relatively simple transmitter – gated ion channels. Trends in Pharmacological Sciences, 17, 319–323.
Johnston, G. A. R. (2005). GABAA receptor channel pharmacology. Current Pharmaceutical Design, 11, 1867–1885.
Kalkman, H. O., Loetschar, E. (2003). GAD (67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis. Journal of Neural Transmission, 110, 803–812.
Kaluev, A. V., Natt, D. Dj. (2003). O roli GAMK v patogeneze trevogy i depressii. [About the role of GABA in pathogenesis of anxiety and depression]. Vestnik biologicheskoy psikhiatrii, N° 12, 10–16.
Khaunina, R. A., Lapin, I. P. (1989). Primenenie phenibuta v psichiatrii i nevrologii i ego mesto sredi drugikh psikhotropnikh sredstv. [Application of phenibut in psychiatry and neurology and its place among the other psychotropic preparates]. Zhurnal nevropatologii i Psikhhiatrii im. S. S. Korsakova. 89, 142–151.
Krnjevic, K., Schwartz, S. (1967). The action of γ-aminobutiric acid on cortical neurons. Experimental Brain Research, 3, 320.
Krnjevic, K. (1974). Chemical nature of synaptic transmission in vertebrates. Physiological Review. 54, 418.
Krogsgaard, P., Frølund, B., Liljefars, T., Ebert, B. (2004). GABAA agonists and partial agonists: THIP (Gaboxadol) as a nonopioid analgesic and a novel type of hypnotic. Biochemical Pharmacology, 68, 1573–1580.
Krogsgaard, Larsen P., Frølund, B., Kristiansen, U., Frydenvang, K., Ebert, B. (1997). GABAA and GABAB receptor agonists, partial agonists, antagonists and modulators – design and therapeutic prospects. European Journal of Pharmaceutical Sciences, 5, 355–384.
Lancel, M., Langabartels, A. (2000). Gamma – amino butyric acid (A) (GABAA) agonist 4,5,6,7-tetrahydroisoxsolo[4,5-c]pyridin-3-ol persistently increases sleep maintenance and intensity during chronic administration to rats. Journal of Pharmacology and. Experimental Therapy. 293, 1084–1090.
Lapin, I. (2001). Phenibut (beta-phenil-GABA): a tranquilizer and nootropic drug. CNS Drug Review. 7, 471–481.
Lavalée, Ph., Urbain, N., Dufresne, C.Bokor, H., Acsády, L. & Deschênes, M. (2005). Feedforward inhibitory control of sensory information in higher-order thalamic nuclei. Journal of Neuroscience, 25, 7489–7498.
Lin, C.-S., Nicolelis, M. A. L., Schneider, J. S., & Chapin, J. K. (1990). A major direct GABAergic pathway from zona incerta to neocortex. Science, 248, 1553–1556.
Lloyd, K.G. (1986). La théorie GABAergique de l'epilepsie. Thérapeutique neurologique, 36 (5), 243–254.
Lubow, R.E. (1989). Latent inhibition and conditioned-attention theory. Cambridge, UK: Cambridge University Press.
Lubow, R. E., & Gewirtz, J.C. (1995). Latent inhibition in humans: Data, theory, and implications for schizophrenia. Psychological Bulletin, 117, 87–103.
Luscher, W. (2002). Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy. Central Nervous System Drugs, 16, 669–695.
Mashkovsky, M. D. (2002). Lekarstvennye sredstva [Pharmaceuticals]. Moscow.: Novaya Volna.
Mathias, S., Zihi, J., Steiger, A., Lancel, M. (2005). Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects. Neuropsychopharmacology, 30, 833–841.
McGreer, P. L., Eccles, J.C. & McGreereer, E. G. (1978). Molecular Neurobiology of the Mammalian Brain, N.Y.: Plenum Press
Mechilane, L. C., Ryago, L. K., Allikmets, L. X. (1990). Farmakologija i klinika fenibuta. [Pharmacology and clinic of phenibut]. Tartu: Tartu University Press
Moroni, F., Forchetti, M. C., Krogssgaard-Larsen, P., Guidotti, A. (1982). Relative disposition of the GABA agonists THIP and muscimol in the brain of the rat. Journal of Pharmacy and Pharmacology. 34, 676–678.
Mortensen, M., Wafford, K. A., Wingrove, P., Ebert, B. (2003). Pharmacology of GABAA receptors exhibiting different levels of spontaneous activity. European Journal of Pharmacology, 476, 17–24.
Onodera, S., Hicks, T. Ph. (1998). Projections from substantia nigra and zona incerta to the cat's nucleus of Darkschewitsch. Journal of Comparative Neurology, 396, 461–482.
Pavlov, I.P. (1954). Lektsiya 22. Obschaya harakteristika dannogo issledovaniya, ego zadacha, ego trudnosti i nashi oshibki. [General description of the investigation, its problems, its hardships and our mistakes]. Izbrannye trudy. (Usievich, M. A., ed.), Moscow: Gosudarstvennoie Uchebno-pedagogicheskoe izdatelstvo MP RSFSR, (pp. 387–401).
Pavlov, I.P. (1973). Dvadtsatiletniy opyt objektivnogo izucheniya vysshey nervnoy deiyatelnosti (povedeniya) zhivotnykh [Twenty years' experience with empirical study of higher nervous activity (behavior) in animals]. Moscow: Nauka.
Perekalin, V. V. & Zobacheva, M. M. (1959). Sintez gamma-amino kislot i pirrolidonov [The synthesis of gamma-amino acids and pyrrolidones] Zhurnal obschey khimii, 29, 2905–2910.
Rode, F., Jensen, D. G., Blackburn-Munro, G., Bjerrum, O.J. (2005). Centrally-mediated antinociceptive actions of GABAA receptor agonists in the rat spared nerve injury model of neuropathic pain. European Journal of Pharmacology, 516, 131–138.
Rudolph, U.Crestani, F., Möler, H. (2001). GABAA receptor subtypes: dissecting their pharmacological functions. Trends in Pharmacological Sciences, 22, 188–194.
Semyanov, A. V. (2002). GAMK-ergischeskoe tormozhenie v CNS: tipy GAMK – receptorov i mechanizmi tonischeskogo GAMK – oposredovannogo deystviya. [GABAergic inhibition in CNS: Types GABA – receptors and mechanisms of tonic GABA mediated inhibitory action]. Neurofisiologiya, 34, 82–92.
Semyanov, A. V. (2004). Diffuse extrasynaptic neurotransmission by means of glutamate and GABA. Diffuznaya vnesinaptischeskaya neuroperedascha posredstvom glutamate i GAMK. Zhurnal vysshey nervnoy deyatelnosti. 54, 68–84.
Shehab, S., McGonigle, D., Hughes, D. I., Todd, A. J., Redgrave, P. (2005). Anatomical evidence for an anticonvulsant relay in the rat ventromedial medulla. Journal of Neuroscience, 22, 1431.
Shmuilevisch, L. M., Kudrin, A. N. (1987). Gamma-aminomaclyanaya kislota i lekarstvennie preparati na ee osnove. [Gamma-aminobutiric acid and drugs containing it]. Farmatsiya, N° 4, 76–80.
Shulgina, G. I. (1976). O funktsional'noyi roli medlennikh kolebaniyi potentsiala i uporyadoschennykh potokov impul'satsii. [On the functional role of potential slow oscillations and regular flows of action potentials]. Zhurnal uspekhi fiziologicheskikh nauk, 1, 47–66.
Shulgina, G. I. (1987). K experimental'nomu i teoretischeskomu obosnovaniyu giperpolarizationnoy theorii vnutrennego tormozheniya. [Experimental and theoretical evidence of hyperpolarization theory of internal inhibition]. Zhurnal uspekhi fiziologischeskikh nauk. 18, 80–97.
Shulgina, G. I. (2005). The neurophysiological validation of the hyperpolarization theory of internal inhibition. The Spanish Journal of Psychology, 8, 86–99.
Shulgina, G. I., Ziablitseva, E. A.(2005). Vliyanie proizvodnogo GAMK phenibuta na obuschenie. [Influence of the GABA derivative phenibut on learning]. Vestnik rossyisky akademii meditsinskikh nauk, 2, 35–40.
Shulgina, G. I., Petricheva, A. P., & Kuznetzova, G.G. (1985). Vliyanie proizvodnogo GAMK – fenibuta na povedenie i aktivnost' nevronov zritelnoy kory krolikov pri vyrabotke oboronitel'nogo refleksa i vnutrennego tormozheniya [Effect of the GABA-derivative – phenibut on the behavior and activity of neurons in the visual cortex of rabbits during conditioning of defensive reflex and internal inhibition]. Zhurnal vysshey nervnoi deyatelnosti, 25, 695–702.
Sitinskiy, I. A. (1977). Gamma-aminomaslyanaya kislota – mediator tormozheniya. [Gamma-aminobutiric acid – mediator of inhibition]. Leningrad: Nauka..
Soriano, E., Frotscher, M. (1989). A GABAergic axo-axonic cell in the fascia dentata controls the main excitatory hippocampal pathway. Brain Research, 503, 170–174.
Sperk, G., Schwarzer, C., Tsunashi, K., Kandlhover, S. (1998). Expression of GABAA receptor subunits in the hippocampus of the rat after kainic acid-induced seizures. Epilepsy Research, 32, 129–139.
Steriade, M. (2005). Sleep, epilepsy and thalamic reticular inhibitory neurons. Trends in Neuroscience, 28, 317–324.
Steriade, M., Gloor, P., Llinas, R. R., Lopes de Silva, F. H., Mesulam, M.M. (1990). Basic mechanisms of cerebral rhythmic activities. Electroencephalography and clinical Neurophysiology, 76, 481–508.
Sukhov, A. G. (1968). K voprosu o korkobikh tormoznikh neyronakh.[On cortical inhibitory neurons] Fiziologicheskiy zhurnal USSR, 54, 270–275.
Talalaenko, A. N. (1989). Farmakologicheskiy analis anxiolititcheskogo deystviya proizvodnich bezodiazepina, GAMK i β- carbolina v razlitschikh (razlichnikh??) testakh naprjazheniya. [Pharmacological analyses of anxiolitic action of derivative of benzodiazepine, GABA, and β - carboline in different tests of stress-reaction]. Farmakologiya i toxikologiya. 52, 26–29.
Tebecis, A.K. (1974). Transmitters and identified neurons in the mammal's central nervous system. Bristol UK: Scientechnica.
Trageser, J. C., Keller, A. (2004). Reducing the uncertainty: gating of peripheral inputs by zona incerta. Journal of Neuroscience, 24, 8911–8915.
Vaitl, D., Bauer, U., Schaler, G., Stark, R., Zimmerman, M.,& Kirsh, P. (2002). Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses. Schizophrenia Research, 55, 147–158.
Voronin, L. G., Sokolov, E. N. (1962). Korkovye mekhanizmy orientirovochnogo refleksa. Otnoshenie orientirovochnogo refleksa k uslovnomu refleksu [The cortical mechanisms of the orienting reflex. The relationship of the orienting reflex to the conditioned reflex]. In Elektroencefalograficheskoe issledovanie vysshey nervnoy deyatelnosti. [Electroencephalographic Research of the Higher Nervous Activity]. Moscow: Nauka, (pp. 310–321).
Wassef, A., Baker, J., Kochan, LD.,(2003). GABA and schizophrenia: a review of basic science and clinical studies. Journal of Clinical Psychopharmacology, 3, 601–640.
Ziablitseva, E. A., Shulgina, G. I. (The characteristics of the nootropic action of phenibut]. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova, 106, 57–58.
Zorn, S.H., Enna, S.J. (1987). The GABA agonist THIP attenuates antinociception in the mouse by modifying central cholinergic transmission. Neuropharmacology, 26, 433–437.